Study demonstrates safety and efficacy of co-administering COVID-19 and flu vaccines
Study co-administered Novavax’s COVID-19 vaccine alongside Seqirus’ flu vaccines
Read More
Tag: seqirus
Approval for Seqirus flu vaccine
Seqirus has announced European approval of its new cell-based quadrivalent influenza vaccine.
Read More
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
